These top 5 stories underscore how 2025 was a year of constant friction at the intersection of public health and political ...
Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...
Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in ...
Panelists discuss how schizophrenia typically evolves through distinct phases—from first-episode psychosis to chronic illness ...
Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH ...
From there, the discussion turns to bispecific antibodies for relapsed/refractory multiple myeloma (RRMM) and the unmet needs ...
Blinatumomab addition to chemotherapy significantly improves survival and reduces relapse in pediatric B-cell acute ...
An immunomodulatory vaccine advancing to phase 3 trials highlights the evolving role of immune system recalibration in cancer treatment. From immunotherapy breakthroughs to early-stage scientific ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback